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Mutagenic properties of terpenes (both synthesis and plant 
derived) have been tested, up to now, as a single molecule. 
A terpenes containing hydro-alcoholic solution deriving from 
frankincense and myrrh resins and hyssop essential oil was 
assayed for mutagenicity by means of Ames test. Extraction tech-
nique conducted with electromagnetic fields at room temperature 
enabled to obtain a solution of free active molecules that did 
not undergo thermal degradation and characterized by biocidal 
activity. In order to verify lack of mutagenic hazard in coming 
into contact with human, the solution was appropriately diluted 
and tested with Salmonella typhimurium TA98, TA1535 and 
YG1024 strains, both in absence and in presence of metabolic 
system S9. For none of the tested conditions a 2-fold increase of 
induced revertants, as regards to spontaneous, was registered. 
The ratio between induced and spontaneous His+ revertants 
(Mutagenic Index) was around 1.00 in all the determinations 
and no statistically significant differences have been identified 
comparing the sample and the negative control. A similar result 
has been obtained for the dose-response curve. In conclusion, 
we verified that tested terpenes solution lacks of mutagenicity on 
Salmonella typhimurium with and without metabolic activator so 
this plant extract can be safely used as biocide.
Introduction
It has been since thousands of years that plants extracts 
have been used as essences, spices and fragrances and 
their properties for prevention and treatment of illnesses 
are known. Plant extracts contain a wide group of mole-
cules, called terpenes, all sharing the same basic struc-
tural composition. Traditional methods of extraction, by 
means of hot temperatures, enable to obtain essential 
oil solutions (in ethanol or methanol), widely available 
on the market, where active principles are only partially 
free to be absorbed.
The hydro-alcoholic solution of terpenes considered in 
this work has been derived from extraction of Boswellia 
sacra (Burseraceae) resin, Commiphora myrrae (Bur-
seraceae) resin and Hyssopus decumbens (Lamiaceae) 
essential oil. They all came from the Arabic penin-
sula. Obtained solution is the result of a new extrac-
tion procedure, called Electromagnetic Field Extraction 
(E.M.F.EX.).
The change in the extraction process consists in a 
system that does not employ neither toxic or dange-
rous chemical solvents nor high temperature or high 
pressure, as normally used for standard laboratory and 
industrial methods. Many natural products in particular 
terpenes, terpenoidis and terpene-like molecular struc-
tures are temperature and/or pressure sensitive. A large 
part of these compounds will have a critical temperature 
point between 50°C and 85°C. At these temperatures, 
the compounds can be inactivated or depolymerized 
forming very small, high reactive oligomers, so the inte-
grity of the extraction will not be preserved. On the op-
posite, operating at room temperature (23°C) and using 
a high intensity variable magnetic field allows to obtain 
pure free molecules in a true solution. The outcome is a 
liquid without heavy metals and toxic or possible aller-
genic substances. So the terpenes, that are diluted into 
the solution, are in a free-like energetic form and totally 
vaporizable, having a very poor attraction force as these 
molecules have a very small molecular radius (ranging 
from 0.1 to 1 nanometre) and a low molecular weight 
(varying from 136 to 520 Daltons).
Preliminary tests allowed to establish that the hydro-
alcoholic solution was characterized by antimicrobial 
power. Considering this finding and expecting a futu-
re employ that requires human exposure, it appeared 
necessary to verify its safety. In fact, this solution can 
be considered as a biocide and, before bringing it on 
the market, it has to fulfill the “precaution principle”, 
as established by Directive 98/8/CE of European Par-
liament [1] acknowledged from the Italian legislation 
as the Legislative Decree 174/2000 [2]. Therefore, the 
efficacy of the solution and its lack of negative effects 
towards humans, animals and the environment must be 
verified at the same time. In particular, to establish com-
plete harmless, the product has to be submitted to several 
assays with the aim of investigating its biological effects 
and exclude citotoxicity, mutagenicity, carcinogenicity 
and reproduction toxicity. Ames test is included among 
the assays to be performed to exclude mutagenicity. On 
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this basis, we evaluated possible mutagenic activity of 
the hydro-alcoholic solution of terpenes obtained by 
E.M.F.EX. extraction method by means of Salmonella 
microsome assay (Ames test) in absence and in presence 
of metabolic activator S9, verifying if it can exert muta-
genic action towards three different strains of Salmonel-
la typhimurium. Assessment of the lack of mutagenicity 
would represent a safety proof since, in the future, the 
extract could be used as a disinfectant.
Methods
Sample composition
Plant’s extract was obtained from Boswellia sacra resin, 
Commiphora myrrae resin and Hyssopus decumbens 
essential oil applying E.M.F.EX. extraction method. 
The solvent was a mixture of distilled water and ethanol 
96% (ratio 1:4). Quantification of terpenes was per-
formed by GC-MS GC-FID, using a Hewlett-Packard 
gas-chromatograph.
Chemicals
Dimethylsulfoxide (DMSO) of high grade purity (99,9% 
from Merck) was used to dilute the sample and all po-
sitive controls. Sodium azide, 2-nitrofluorene, 1,8 di-
nitropirene, benzo-[a]-pyrene, 2-aminoanthracene and 
aminofluorene, chosen as positive controls, were all 
purchased from Sigma (Milan, Italy). Purity of all che-
micals used in the assays was higher than 95%.
Sample
The sample was a plant’s extract. Knowing antimicro-
bial effect of the solution, preliminary assays have been 
conducted in order to verify that chosen doses did not 
inhibit bacterial growth. Briefly, paper discs soaked 
with different doses of the solution were placed on agar 
medium uniformly seeded with the different bacterial 
strains that have been considered in this study. The pla-
tes were incubated at 37°C and checked at 24, 48 and 
72 hours, in order to verify the absence of inhibition 
halo. This procedure permitted the identification of a 
wide range of dilutions starting from 1:750 to 1:100, 
lacking antimicrobial activity, in order to evaluate 
possible mutagenicity avoiding toxic or biocidal action 
towards Salmonella typhimurium. The solvent was 
always DMSO.
Metabolic activation system (S9 mixture)
Lyophilized rat liver S9 fraction induced by Aroclor 
1254 was obtained from Moltox (Molecular Toxicolo-
gy Inc., Boone, NC, USA). The 10% S9 mixture was 
freshly prepared as described in details by Maron and 
Ames [3].
Bacterial strains
Mutagenicity testing was performed considering TA98, 
TA1535 and YG1024 Salmonella typhimurium strains. 
For all assays, an overnight culture in Oxoid Nutrient 
Broth No. 2 incubated at 37°C was obtained.
Mutagenicity testing
Mutagenic activity of the sample was determined using 
the plate incorporation technique which preincubation 
on the Salmonella typhimurium strains in the presence 
or absence of metabolic activation (S9 500 µl/plate) [3]. 
Briefly, 100 µl of an overnight grown culture, 100 µl of 
sample (diluted in DMSO), 500 µl of sodium-phosphate 
buffer (S9-) or 500 µl of S9 mix (S9+), after 30 minutes 
of preincubation at 37°C, were mixed with 2 ml of top 
agar which was then poured onto a minimal glucose 
plate. In each assays, a positive and a negative control 
were included. Negative controls were assayed with the 
same volume of the vehicle. The positive controls in the 
absence of metabolic activator were: 2- nitrofluorene 
(1 µg/plate) for TA98; sodium azide (1 µg/plate) for 
TA1535 and 1,8 dinitropirene (1 µg/plate) for YG1024. 
The positive controls in the presence of metabolic activa-
tor were: benzo-[a]-pyrene (5 µg/plate) for TA98; 2-ami-
noanthracene (1 µg/plate) for TA1535 and aminofluorene 
(0,2 µg/plate) for YG1024. Each determination was made 
in triplicate and at least two independent experiments 
have been carried out to confirm the results [4]. Plates 
were incubated at 37°C for 72 hours in the dark and then 
revertant His+ bacteria colonies were scored. The Muta-
genic Index (M.I.) was calculated as the ratio between 
number of histidine revertants induced per plate of the 
test sample and spontaneous revertants of the negative 
control. His+ values obtained for positive and negative 
control of each strain confirm the results previously 
achieved in our laboratory [5]. Mutagenic activity results 
were considered as positive when the following require-
ments were fulfilled [6, 7]: a) at least for one of tested 
doses, the ratio between induced and control His+ is equal 
or higher than 2; b) a significant response for analysis of 
variance (ANOVA, p < 0.05) could be reached; c) indu-
ced revertants versus tested doses created a positive and 
representative (p < 0.01) dose-response curve. Mutagenic 
activity is expressed as number of His+ induced rever-
tants (mean ± standard deviation) for all tested doses. 
In addition, the ratio between induced and spontaneous 
revertants was calculated as Mutagenic Index.
Statistical analysis
Comparisons between His+ revertants induced by the 
sample and spontaneous revertants were performed with 
ANOVA test for analysis of variance and coefficient 
regression of dose-response curve. Both tests were per-
formed with Stat View Statistical Software version 5.1 
(SAS Institute Inc., USA).
Results
Hydro-alcoholic solution of plants deriving extracts 
contains, on the whole, 31.847 mg/L of terpenes, mainly 
monoterpenes (13.889 mg/L) and triterpenes (8.323 mg/
L). Main components are listed in Table I.
Sample mutagenicity analyzed according to Ames test 
on three different Salmonella typhimurium strains is 
shown in Tables II-IV. Considered doses were chosen 
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Tab. I. chemical composition of sample (main components determined by gc/ms – gc fid analysis).
Solvent
ethanol 80% 
distilled water 20% 
TERPENES 31.847 mg/l
monoterpenes
1,8 cineole
p-mentanol
linalool
α-terpinol
α-terpinene
lynalil acetate
isopulegol
13.889 mg/l
diterpenes
incensole oxide
incensole acetates (n-octanol and n-octylacetates)
verticiol
4.042 mg/l
triterpenes
α- β - γ commiphoric acids
α-amirin
α-boswellic acid
acetyl-β-boswellic acid
11-ketoboswellic acid
acetyl- 11-keto-bosewellacid (aKBa)
8.323 mg/l
sesquiterpenes
1,3 furanodiene
1,4 furanodiene
2-metossifuranodiene
5.593 mg/l
the solution contains citric acid (15.000 mg/l) as excipient, stabilizer and terpenes synergist.
Tab. II. mutagenic activity tested with ames test on ta98 strain in the absence and in the presence of metabolic activator (s9).
TA98 Induction of revertants
Dose -S9 +S9
Mean  ± SD Mutagenicity
Index
(M.I.)
Mean  ± SD Mutagenicity
Index
(M.I.)
0 27 ± 6 – 39 ± 5 –
1:750 27 ± 4 1.00 35 ± 6 0.89
1:500 25 ± 4 0.94 36 ± 8 0.92
1:250 24 ± 2 0.88 42 ± 10 1.08
1:100 23 ± 2 0.84 39 ± 4 1.00
p 0.228 0.324
dose 0 (negative control): 100 µl dmso. positive controls were 2-nitrofluorene (1 µg/plate): 108 ± 10.8 for s9- and benzo[a]pyrene (5 µg/plate): 327 ± 28.4 
for s9+. mutagenicity index (m.i.) represents ratio of his+ revertants induced by the sample/spontaneous his+ revertants induced by negative control.
Tab. III. mutagenic activity tested with ames test on ta1535 strain in the absence and in the presence of metabolic activator (s9).
TA1535 Induction of revertants
Dose -S9 +S9
Mean  ± SD Mutagenicity
Index
(M.I.)
Mean  ± SD Mutagenicity
Index
(M.I.)
0 24 ± 6 – 18 ± 3 –
1:750 24 ± 7 1.00 19 ± 6 1.05
1:500 19 ± 8 0.79 17 ± 4 0.95
1:250 24 ± 9 1.00 20 ± 3 1.12
1:100 20 ± 5 0.83 21 ± 4 1.21
p 0.484 0.291
dose 0 (negative control): 100 µl dmso. positive controls were sodium azide (1 µg/plate): 190 ± 9.3 for s9- and 2-aminoanthracene (1 µg/plate): 196 ± 7.2 
for s9+. mutagenicity index (m.i.) represents ratio of his+ revertants induced by the sample/spontaneous his+ revertants induced by negative control.
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in order to test possible mutagenic activity on bacterial 
strains excluding high doses that could exert antimicro-
bial action. In all assays, no toxicity occurred: no reduc-
tion in the number of His+ revertant bacterial colonies 
and/or thinning of auxotrophic background growth have 
been noticed. Table II reports mutagenicity tested on 
Salmonella typhimurium TA98 strain. When the sample 
was assayed without metabolic activator, the number of 
revertants was always similar or slightly lower the ne-
gative control. Likewise, the doses that have been tested 
in presence of S9 metabolic system exhibited a number 
of His+ induced revertants equivalent. In both cases, 
no statistically significant difference could be found 
(p = 0.228 and p = 0.324, respectively). Mutagenicity 
Index was about 1.00. Mutagenicity assayed on TA1535 
Salmonella typhimurium strain confirmed similar resul-
Tab. IV. mutagenic activity tested with ames test on yg1024 strain in the absence and in the presence of metabolic activator (s9).
YG1024 Induction of revertants
Dose -S9 +S9
Mean  ± SD Mutagenicity
Index
(M.I.)
Mean  ± SD Mutagenicity
Index
(M.I.)
0 31 ± 3 – 76 ± 11 –
1:750 28 ± 5 0.91 77 ± 13 1.01
1:500 28 ± 5 0.92 84 ± 9 1.11
1:250 29 ± 6 0.95 81 ± 6 1.07
1:100 25 ± 4 0.82 78 ± 8 1.03
p 0.160 0.516
dose 0 (negative control): 100 µl dmso. positive controls were 1,8 dinitropirene (1 µg/plate): 285 ± 12.4 for s9- and aminofluorene (0,2 µg/plate): 
211 ± 16.9 for s9+. mutagenicity index (m.i.) represents ratio of his+ revertants induced by the sample/spontaneous his+ revertants induced by negative 
control.
Fig. 1. dose-dependent mutagenicity towards ta98, ta1535 and yg1024 salmonella typhimurium strains with and without metabolic 
activator (s9).
ts, as described in Table III. Direct mutagenic activity 
was absent, as the number of induced revertants was 
equal or slightly lower than revertants induced by dose 
zero (p = 0.484). A comparable outcome was provided 
when the sample has been tested in presence of meta-
bolic activator (p = 0.291). No significant differences 
between revertant’s values have been established also 
for this strain, but, in this case, as indicated by the Mu-
tagenicity Index, values resulted the same or impercep-
tibly higher than 1.00.
Assessment of mutagenicity on YG1024 Salmonella 
typhimurium strain is presented in Table IV. Sample 
tested in absence of metabolic activator never reached 
values of induced His+ revertants equal or higher as 
spontaneous, as shown by the Mutagenicity Index 
which was inferior than 1.00 in all the determinations. 
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As it has been already pointed out for other strains, 
the presence of metabolic system generated a number 
of revertant colonies slightly more elevated than only 
solvent. The comparison between spontaneous and in-
duced revertants failed to achieve a statistically signi-
ficant difference (p = 0.160 without S9 and p = 0.516 
with S9). In all the conditions that have been tested in 
our laboratory, no increase in the number of His+ rever-
tants compared with the solvent was observed, while 
positive controls always induced a clear mutagenic 
response. When considering the dose-response curve 
(Fig. 1), all the tested conditions showed the same 
flat trend, although mean mutagenicity levels showed 
differences related to the strain and metabolic system 
activator presence.
Discussion and conclusios
A solution containing terpenes extracted from Boswellia 
sacra resin, Commiphora myrrae resin and Hyssopus 
decumbens essential oil without using hot temperature 
technique has been assayed for mutagenic potential. The 
new extraction method allows to obtain molecules that, 
lacking of bonds, are free to react and exert their activi-
ties. This ability enhances its biological effects, in which 
the killing of microorganisms is included, so resulting 
particularly interesting regarding future human applica-
tions, given the absence of negative outcomes and its 
favorable action, potentially at higher levels than extracts 
at present available on the market.
Our study clearly shows that the hydro-alcoholic solu-
tion we considered has no mutagenicity in Salmonella 
microsome assay on TA98, TA1535 and YG1024 
strains, with or without metabolic activator system. 
Other recent studies on the same issue reported negative 
results when investigating mutagenic activity of molecules 
belonging to terpenes as well. In most cases, the analysis 
considered a single synthetic molecule belonging to mo-
noterpenes [8] or sesquiterpenes [9, 10] but similar results 
have been reached. Assay of natural extracts, as the case 
of triterpenes resulting from bamboo shaving powder [11] 
or basil essential oil containing mainly the monoterpene 
linalool [12] achieved similar negative results.
In summary, our data show that the evaluated hydro-
alcoholic solution obtained from Boswellia sacra resin, 
Commiphora myrrae resin and Hyssopus decumbens es-
sential oil applying E.M.F.EX. extraction method has not 
mutagenic properties in the Salmonella assay, confirming 
lack of mutagenicity for this class of molecules.
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